Showing results (61-70 of 193) with videos related to
Sort By:
Pageof 20
Journal of the International AIDS Society|November 14, 2014
Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D studyColette Smith, Lene Ryom, Antonella d'Arminio Monforte, et al.PLOS Mental Health|February 9, 2026
Testing for Hepatitis B and C virus and HIV in mental healthcare settings in England between 2015-2021Matthew Hibbert, Ruth Simmons, Peter Dearman, et al.AIDS (London, England)|March 18, 2011
Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individualsCristina Mussini, Andrea Cossarizza, Caroline Sabin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2017
Measurement of Retinal Vessels as a Biomarker of Cerebrovascular Aging in Older HIV-Positive Men Compared With ControlsLewis Haddow, Rosanna Laverick, Irene Leung, et al.Thorax|November 3, 2012
Risk of tuberculosis following HIV seroconversion in high-income countriesSara Lodi, Julia del Amo, Antonella d'Arminio Monforte, et al.Journal of Viral Hepatitis|October 24, 2024
The Camden and Islington Viral Hepatitis Identification Tool (CIVHIT): Use of a Clinical Database Case-Finding Tool for Hepatitis B, Hepatitis C and HIV in Primary CareDavid Etoori, Sara Cococcia, Ankur Srivastava, et al.Journal of the International AIDS Society|November 15, 2014
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failureAnna Schultze, Roger Paredes, Caroline Sabin, et al.AIDS (London, England)|February 8, 2011
The impact of HIV drug resistance testing on changes to treatmentLoveleen Bansi, Colette Smith, Andrew Phillips, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2010
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART)Loveleen Bansi, Anna Maria Geretti, David Dunn, et al.Gastroenterology|December 26, 2012
Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997Jannie van der Helm, Ronald Geskus, Caroline Sabin, et al.Pageof 20